Boston Scientific India Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 28.23 Cr
as on 16-11-2024
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 72.35%
(FY 2023)
- Profit -120.16%
(FY 2023)
- Ebitda 12.64%
(FY 2023)
- Net Worth -1.22%
(FY 2023)
- Total Assets 50.99%
(FY 2023)
About Boston Scientific India
The Corporate was formerly known as Guidant India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 28.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Boston Scientific India Private Limited India is Lipika Arora as COMPANY SECRETARY. Madan Rohinikrishnan and Deepak Khamesra serve as directors at the Company.
- CIN/LLPIN
U33119DL2003FTC121242
- Company No.
121242
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
09 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Boston Scientific India Private Limited offer?
Boston Scientific India Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Catheter.
Who are the key members and board of directors at Boston Scientific India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madan Rohinikrishnan  | Managing Director | 29-Mar-2024 | Current |
| Lipika Arora | Company Secretary | 10-Dec-2021 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Khamesra | Director | 04-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Boston Scientific India.
Boston Scientific India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.35% increase. The company also saw a substantial fall in profitability, with a 120.16% decrease in profit. The company's net worth dipped by a decrease of 1.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Boston Scientific India?
In 2023, Boston Scientific India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Boston Scientific India?
Boston Scientific India has a workforce of 269 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Boston Scientific India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Boston Scientific India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
